Dr. Uma Mahadevan, MD

Dr. Mahadevan practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Mahadevan's NPI, 1851355283, was assigned on April 13, 2006. Dr. Mahadevan graduated from SUNY Downstate Health Sciences University in 1995. Dr. Mahadevan holds California license A66529.

Dr. Mahadevan's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Mahadevan's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Mahadevan to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahadevan practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Mahadevan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Mahadevan is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Mahadevan's licenses on file in 2 states: California and Minnesota.

Dmand AI lists chronic inflammatory bowel disease (IBD), colonoscopy, gastroduodenitis, intestinal or bowel obstruction and upper GI endoscopy among the conditions Dr. Mahadevan treats.

CMS data shows 120 Medicare services from Dr. Mahadevan across 4 procedure codes in 2024, for 81 Medicare patients. Medicare paid $8,695 for them.

CMS counts 81 Medicare patients who saw Dr. Mahadevan in 2024. The largest group is 65 to 74, with 47 patients. 60% of them have high cholesterol, and 56% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mahadevan's median patient age at 47, with 59% women.

In 2024, Dr. Mahadevan wrote 62 Medicare Part D claims for 23 patients. 44% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $161,147 in total drug cost. In 2023, CMS named 31 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mahadevan for performance year 2024, reported as part of a group. Dr. Mahadevan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mahadevan as offering telehealth. CMS counts 36 procedures of colonoscopy by Dr. Mahadevan, more than 57% of the clinicians it reports for that procedure.

Dmand AI links 152 papers to Dr. Mahadevan, published from 2007 to 2025. 2024 was the busiest year, with 12. The most frequent topics are Inflammatory Bowel Diseases, Pregnancy Complications and Colitis, Ulcerative. Dr. Mahadevan has published most often in Inflamm Bowel Dis. Dr. Mahadevan's most frequent co-authors are Sunanda V. Kane, MD, William J. Sandborn, MD and Michael George Kattah, MD, PhD.

Dmand AI links Dr. Mahadevan to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Crohn Disease, Inflammatory Bowel Diseases and Colitis, Ulcerative. University of California, San Francisco sponsors the most, 3.

CMS Open Payments shows 325 general payments to Dr. Mahadevan from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $99,123. It also lists 7 research payments totaling $7,010 from 2020 to 2025.

Dmand AI lists 1 award for Dr. Mahadevan, most recently CMS Stage 1 EHR in 2013.

Dr. Mahadevan graduated from SUNY Downstate Health Sciences University in 1995. Dr. Mahadevan is a member of ACG.

Dr. Mahadevan is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.